Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome

Pediatric Emergency Care

Volumn 23, Issue 9, 2007, Pages 659-661

  Abend, Nicholas S ^a   Bonnemann, Carsten G ^a   Licht, Daniel J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Guillain Barr syndrome; Hypertension; Posterior reversible leukoencephalopathy syndrome; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; GABAPENTIN; IMMUNOGLOBULIN; LABETALOL; LORAZEPAM; PHENYTOIN;

ADOLESCENT; AREFLEXIA; ARTICLE; AUTONOMIC NEUROPATHY; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY WARD; EPILEPTIC STATE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HYPERTENSION ENCEPHALOPATHY; LEUKOENCEPHALOPATHY; LOADING DRUG DOSE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; WEAKNESS;

ADOLESCENT; AMINES; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; CYCLOHEXANECARBOXYLIC ACIDS; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; GAMMA-AMINOBUTYRIC ACID; GUILLAIN-BARRE SYNDROME; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; IMMUNOGLOBULINS; LABETALOL; PHENYTOIN; SPINAL PUNCTURE; STATUS EPILEPTICUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548806495     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31814b2ddd     Document Type: Article

References (36)

1. Ropper AH. The Guillain-Barré syndrome. N Engl J Med. 1992;326(17):1130-1136.
2. Jackman NL, Klig JE. Lower extremity pain in a three year old: manifestations of Guillain-Barré syndrome. Pediatr Emerg Care. 1998;14(4):272-274.
3. Paradiso G, Tripoli J, Galicchio S, et al. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal. Ann Neurol. 1999;46(5):701-707.
4. Oh SJ, LaGanke C, Claussen GC. Sensory Guillain-Barré syndrome. Neurology. 2001;56(1):82-86.
5. Seneviratne U, Gunasekera S. Acute small fibre sensory neuropathy: another variant of Guillain-Barré syndrome? J Neurol Neurosurg Psychiatry. 2002;72(4):540-542.
6. Ropper AH, Wijdicks EF, Shahani BT. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome. Arch Neurol. 1990;47(8):881-887.
7. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol. 2001;58(6):913-917.
8. Flachenecker P, Wermuth P, Hartung HP, et al. Quantitative assessment of cardiovascular autonomic function in Guillain-Barré syndrome. Ann Neurol. 1997;42(2):171-179.
9. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med. 1971;50(6):772-780.
10. Sladky J. Guillain-Barré syndrome. In: Jones H, DeVivo D, Darras B, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Philadelphia: Butterworth-Heinemann; 2003:407-424.
11. Bradshaw DY, Jones HR Jr. Guillain-Barré syndrome in children: clinical course, electrodiagnosis, and prognosis. Muscle Nerve. 1992;15(4):500-506.
12. Pfeiffer G, Schiller B, Kruse J, et al. Indicators of dysautonomia in severe Guillain-Barré syndrome. J Neurol. 1999;246(11):1015-1022.
13. Wijdicks E. Gillain-Barré syndrome. In: The Clinical Practice of Critical Care Neurology. New York: Oxford University Press; 2003:403-421.
14. Burns TM, Lawn ND, Low PA, et al. Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve. 2001;24(7):963-965.
15. Kogan BA, Solomon MH, Diokno AC. Urinary retention secondary to Landry-Guillain-Barré syndrome. J Urol. 1981;126(5):643-644.
16. Wheeler JS Jr, Siroky MB, Pavlakis A, et al. The urodynamic aspects of the Guillain-Barré syndrome. J Urol. 1984;131(5):917-919.
17. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494-500.
18. Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES). Med Sci Monit. 2005;11(11):CR549-CR553.
19. Ozyurek H, Oguz G, Ozen S, et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005;20(12):990-993.
20. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001;24(5):361-364.
21. Schwartz RB. Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist. 2002;8(1):22-34.
22. Dixon SF, Appleton RE, Davidson JE, et al. Acute, severe self-limiting dysautonomia and hypertensive encephalopathy. Pediatr Neurol. 2001;25(4):319-324.
23. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol. 1999;14(5):277-281.
24. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J. 2005;35(2):83-90.
25. Del Giudice E, Aicardi J. Atypical aspects of hypertensive encephalopathy in childhood. Neuropadiatrie. 1979;10(2):150-157.
26. Van Diest D, Van Goethem JW, Vercruyssen A, et al. Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: coincidence or causative relation? Clin Neurol Neurosurg. 2007;109:58-62.
27. Elahi A, Kelkar P, St Louis EK. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome. Neurocrit Care. 2004;1(4):465-468.
28. Richards AM, Nicholls MG, Beard ME, et al. Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome. Postgrad Med J. 1985;61(711):53-55.
29. Okada T, Hiyoshi K, Noto N, et al. A case of Guillain-Barré syndrome accompanied by sympathetic overactivity and hypertensive encephalopathy. Acta Paediatr. 1996;85(8):1006-1008.
30. Gande AR, Taylor IR, Nolan KM. Autonomic instability and hypertension resulting in subarachnoid haemorrhage in the Guillain-Barré syndrome. Intensive Care Med. 1999;25(12):1432-1434.
31. Hughes RA, Raphael JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2006;(1):CD002063.
32. Mathy I, Gille M, Van Raemdonck F, et al. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg. 1998;98(4):347-351.
33. Voltz R, Rosen FV, Yousry T, et al. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology. 1996;46(1):250-251.
34. Harkness K, Howell SJ, Davies-Jones GA. Encephalopathy associated with intravenous immunoglobulin treatment for Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1996;60(5):586.
35. Doss-Esper CE, Singhal AB, Smith MS, et al. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barré syndrome. J Neuroimaging. 2005;15(2):188-192.
36. Hamrock DJ. Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2006;6(4):535-542.